A Phase I/II Study to Evaluate the Safety and efficacy of Liposomes Encapsulating Paclitaxel (EndoTAG-1 [ET]) in Patients with Refractory, Nonresectable Head and Neck Squamous Cell Carcinoma.
Phase of Trial: Phase I/II
Latest Information Update: 28 Nov 2015
At a glance
- Drugs Paclitaxel (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2015 New trial record